ELEKTA TO DELIVER FIRST LEKSELL GAMMA KNIFE® UNIT TO RUSSIA

ELEKTA TO DELIVER FIRST LEKSELL GAMMA KNIFE® UNIT TO RUSSIABurdenko Neurosurgical Institute in Moscow will add non-invasive brainsurgery to its range of advanced treatment methodsRecently, Elekta finalized the contract with Finance Leasing Company(Moscow, Russia) and Neurosurgical Business Center (NBC) for BurdenkoNeurosurgical Institute to deliver Leksell Gamma Knife®, the goldstandard equipment for non-invasive Gamma Knife® surgery. This LeksellGamma Knife® unit is the first to be installed in Russia, serving apreviously unmet need for non-invasive treatment of small to medium sizeintracranial lesions."We are very excited about the prospect of adding Leksell Gamma Knife®to our advanced treatment methods here at Burdenko", says Dr. NikolayAlexandrovich Konovalov, Director of the Institute. "Continuing ourtradition of being at the forefront of microsurgery and minimallyinvasive treatments, the addition of Gamma Knife® surgery will provideus with a method to treat a variety of brain tumors, vascularmalformations and functional diseases that will be of great benefit toour patients. The non-invasive technique of Gamma Knife® surgery offersimportant benefits. We are in high demand for these treatments and Iexpect a high patient volume on our Leksell Gamma Knife® unit", DrKonovalov concludes."Gamma Knife® surgery revolutionized the treatment of brain disorderswhen it was introduced over thirty years ago. Today, the potential forits use and the benefits that it brings are bigger than ever. It is withgreat pride that we now are going to supply the first Leksell GammaKnife® unit to Russia", says Thomas Meyer von der Twer, Director ofEuropean sales of neurosurgery products at Elekta, and continues: "It isalso an honor to welcome the esteemed Dr Konovalov and his colleagues toLeksell Gamma Knife Society and to the sharing of experiences, newresults and solutions to clinical problems that to this day has producedmore than 2,000 scientific papers, documenting the results of varioustreatments with Leksell Gamma Knife®".To date, well over 250,000 patients around the world have been treatedwith Leksell Gamma Knife®, and each year more than 30,000 new patientsare treated at the close to 200 units installed around the world.The total payment for the Leksell Gamma Knife® unit to BurdenkoNeurosurgical Institute will amount to 3,8 MEUR. The order was booked byElekta in February. For further information, please contact:International: Peter Ejemyr, Group VP Corporate Communications, ElektaAB (publ), Phone: +46 733 611 000, e-mail: peter.ejemyr@elekta.comUnited States: Lars Jonsteg, VP Investor Relations North America,Elekta, USA Phone: +1 770-670-2419, e-mail: lars.jonsteg@elekta.comElekta is a world-leading supplier of advanced and innovative radiationoncology and neurosurgery solutions and services for precise treatmentof cancer and brain disorders. Elekta's solutions are clinicallyeffective, cost efficient and gentle to the patient.For additional information about Elekta, please visit www.elekta.com------------------------------------------------------------This information was brought to you by Waymaker http://www.waymaker.netThe following files are available for download:http://www.waymaker.net/bitonline/2004/03/25/20040325BIT00530/wkr0001.doc http://www.waymaker.net/bitonline/2004/03/25/20040325BIT00530/wkr0002.pdf